1. COD reduction by TiO2/graphene photocatalytic treatment of ethylene dichloride in wastewater. Issue 28 (14th June 2016) Authors: Maleki, Siamak Azimi; Mirzaei, Masoome; Azimi, Alireza Journal: Desalination and water treatment Issue: Volume 57:Issue 28(2016) Page Start: 13207 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Differentiation of human endometrial stem cells into urothelial cells on a three‐dimensional nanofibrous silk–collagen scaffold: an autologous cell resource for reconstruction of the urinary bladder wall. (14th January 2013) Authors: Shoae‐Hassani, Alireza; Mortazavi‐Tabatabaei, Seyed Abdolreza; Sharif, Shiva; Seifalian, Alexander Marcus; Azimi, Alireza; Samadikuchaksaraei, Ali; Verdi, Javad Journal: Journal of tissue engineering and regenerative medicine Issue: Volume 9:Number 11(2015) Page Start: 1268 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Enhanced validation of antibodies for research applications. Issue 1 (December 2018) Authors: Edfors, Fredrik; Hober, Andreas; Linderbäck, Klas; Maddalo, Gianluca; Azimi, Alireza; Sivertsson, Åsa; Tegel, Hanna; Hober, Sophia; Szigyarto, Cristina; Fagerberg, Linn; Feilitzen, Kalle; Oksvold, Per; Lindskog, Cecilia; Forsström, Björn; Uhlen, Mathias Journal: Nature communications Issue: Volume 9:Issue 1(2018) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Silencing of CEBPB-AS1 modulates CEBPB expression and resensitizes BRAF-inhibitor resistant melanoma cells to vemurafenib. Issue 5 (October 2020) Authors: Vidarsdottir, Linda; Fernandes, Rita Valador; Zachariadis, Vasilios; Das, Ishani; Edsbäcker, Elin; Sigvaldadottir, Ingibjorg; Azimi, Alireza; Höiom, Veronica; Hansson, Johan; Grandér, Dan; Egyházi Brage, Suzanne; Pokrovskaja Tamm, Katja Journal: Melanoma research Issue: Volume 30:Issue 5(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors. Issue 3 (5th March 2018) Authors: Azimi, Alireza; Caramuta, Stefano; Seashore‐Ludlow, Brinton; Boström, Johan; Robinson, Jonathan L; Edfors, Fredrik; Tuominen, Rainer; Kemper, Kristel; Krijgsman, Oscar; Peeper, Daniel S; Nielsen, Jens; Hansson, Johan; Egyhazi Brage, Suzanne; Altun, Mikael; Uhlen, Mathias; Maddalo, Gianluca Journal: Molecular systems biology Issue: Volume 14:Issue 3(2018) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The effects of amantadine on traumatic brain injury outcome: a double-blind, randomized, controlled, clinical trial. (3rd July 2018) Authors: Ghalaenovi, Hossein; Fattahi, Arash; Koohpayehzadeh, Jalil; Khodadost, Mahmoud; Fatahi, Neda; Taheri, Morteza; Azimi, Alireza; Rohani, Sadra; Rahatlou, Hessam Journal: Brain injury Issue: Volume 32:Number 8(2018) Page Start: 1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Thermal proteome profiling identifies PIP4K2A and ZADH2 as off‐targets of Polo‐like kinase 1 inhibitor volasertib. Issue 7 (18th June 2021) Authors: Goroshchuk, Oksana; Kolosenko, Iryna; Kunold, Elena; Vidarsdottir, Linda; Pirmoradian, Mohammad; Azimi, Alireza; Jafari, Rozbeh; Palm‐Apergi, Caroline Journal: FASEB journal Issue: Volume 35:Issue 7(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗